Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT01350310
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT01350310
-
- Other papers using this trial's data
- Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Slovenia
- Registry status
- Completed
Technical summary
Registry record NCT01350310. Randomized; single masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2014-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
- Acronym
- NOGA-DCM
- Condition
- Dilated Cardiomyopathy
- Condition
- Chronic Heart Failure
- Intervention (Procedure)
- Intramyocardial injection
- Intervention (Procedure)
- Intracoronary injection
- Intervention (Procedure)
- Intramyocardial injection
- Lead sponsor
- University Medical Centre Ljubljana
- Collaborator
- The Methodist Hospital Research Institute
- Collaborator
- Stanford University
Record details
- Record id
cardio:ct-nct01350310- Content hash
d569e4f5aa228e66d2502b49eaceda50789219e4b4a3ac09749bbdb4b92a3fe1